Ignite Creation Date:
2024-05-06 @ 4:06 PM
Last Modification Date:
2024-10-26 @ 2:03 PM
Study NCT ID:
NCT04870112
Status:
TERMINATED
Last Update Posted:
2024-03-08
First Post:
2021-04-16
Brief Title:
A Study to Evaluate Subcutaneous Durvalumab in Patients With Non-Small Cell Lung Cancer and Small Cell Lung Cancer
Sponsor:
Organization:
AstraZeneca